ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 760289 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 760289; 2) Community: the network communities that were significantly associated with the response to NSC 760289; 3) Molecule: the relationships between components within communities and NSC 760289; 4) MDR: the compounds that were significantly associated with the NSC 760289.

NSC Compound Enrichment Correlation
NSC 339137 PHYSALOLACTONE 0.0135588245836371 0.38186367
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0135588245836371 0.2433338
NSC 624657 ANTINEOPLASTIC-624657 0.0135588245836371 0.18180782
NSC 643838 Null 0.0135588245836371 0.26787329
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0135588245836371 0.17753462
NSC 681632 Camptothecin Derivative 0.0135588245836371 0.45981687
NSC 690248 Null 0.0135588245836371 0.15277786
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0135588245836371 0.24392275
NSC 697504 Null 0.0135588245836371 0.2282904
NSC 702359 Null 0.0135588245836371 0.36153917
Total:66  Current:14    [First] [Prev] [Next] [Last]